CETP and PRKACG

Number of citations of the paper that reports this interaction (PubMedID 21988832)
87

Data Source:
BioGRID (two hybrid)

		CETP	PRKACG
Description		cholesteryl ester transfer protein	protein kinase cAMP-activated catalytic subunit gamma
Image			No pdb structure
GO Annotations	Cellular Component	Extracellular Region Extracellular Space Vesicle High-density Lipoprotein Particle Extracellular Exosome	Nucleus Nucleoplasm Cytosol Ciliary Base
	Molecular Function	Phospholipid Transporter Activity Lipid Binding Cholesterol Binding Triglyceride Binding Phosphatidylcholine Binding Cholesterol Transfer Activity	Protein Serine/threonine Kinase Activity AMP-activated Protein Kinase Activity CAMP-dependent Protein Kinase Activity Protein Binding ATP Binding Protein Kinase A Regulatory Subunit Binding Protein Serine Kinase Activity
	Biological Process	Triglyceride Metabolic Process Lipid Transport Cholesterol Metabolic Process Negative Regulation Of Macrophage Derived Foam Cell Differentiation Regulation Of Cholesterol Efflux Phospholipid Transport Cholesterol Transport Positive Regulation Of Cholesterol Transport Triglyceride Transport Very-low-density Lipoprotein Particle Remodeling Low-density Lipoprotein Particle Remodeling High-density Lipoprotein Particle Remodeling Cholesterol Homeostasis Reverse Cholesterol Transport Phosphatidylcholine Metabolic Process Lipid Homeostasis Phospholipid Homeostasis Triglyceride Homeostasis Intermembrane Lipid Transfer Positive Regulation Of Phospholipid Transport	Renal Water Homeostasis Protein Phosphorylation Spermatogenesis Male Gonad Development Protein Kinase A Signaling High-density Lipoprotein Particle Assembly
Pathways		LDL remodeling HDL remodeling NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux	PKA-mediated phosphorylation of CREB PKA-mediated phosphorylation of key metabolic factors Triglyceride catabolism PKA activation PKA activation in glucagon signalling DARPP-32 events Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Glucagon-like Peptide-1 (GLP1) regulates insulin secretion Rap1 signalling Regulation of insulin secretion Vasopressin regulates renal water homeostasis via Aquaporins VEGFA-VEGFR2 Pathway CREB1 phosphorylation through the activation of Adenylate Cyclase CREB1 phosphorylation through the activation of Adenylate Cyclase Degradation of GLI1 by the proteasome Degradation of GLI2 by the proteasome GLI3 is processed to GLI3R by the proteasome Hedgehog 'off' state CD209 (DC-SIGN) signaling MAPK6/MAPK4 signaling RET signaling HDL assembly ROBO receptors bind AKAP5 Regulation of glycolysis by fructose 2,6-bisphosphate metabolism ADORA2B mediated anti-inflammatory cytokines production ADORA2B mediated anti-inflammatory cytokines production FCGR3A-mediated IL10 synthesis FCGR3A-mediated IL10 synthesis Factors involved in megakaryocyte development and platelet production
Drugs		Torcetrapib
Diseases
GWAS		Advanced age-related macular degeneration ( 26691988) Age-related macular degeneration ( 23455636 21665990) Apolipoprotein A1 levels ( 32203549 33730874 17463246) Apolipoprotein B levels ( 32203549) Aspartate aminotransferase levels ( 33547301) Biochemical measures ( 19260141) Blood metabolite levels ( 24816252) C-reactive protein levels or HDL-cholesterol levels (pleiotropy) ( 27286809) C-reactive protein levels or triglyceride levels (pleiotropy) ( 27286809) Cardiovascular disease risk factors ( 21943158) Cardiovascular risk factors ( 20838585) Cholesterol ( 20066028) Cholesterol efflux capacity ( 30369316) Cholesterol efflux capacity (cAMP stimulated assay) ( 30369316) Cholesterol, total ( 24097068 24886709 20686565 26582766) Cholesteryl ester transfer protein levels ( 29728394) Coronary artery disease ( 29212778) Coronary artery disease (myocardial infarction, percutaneous transluminal coronary angioplasty, coronary artery bypass grafting, angina or chromic ischemic heart disease) ( 28714975) Diisocyanate-induced asthma ( 25918132) Early age-related macular degeneration ( 32843070) Exudative age-related macular degeneration ( 25629512) HDL cholesterol ( 23726366 24097068 20031538 29404214 19359809 20031564 21909109 28270201 24507774 18193043 18193044 20864672 26160806 19060906 23505323 19060910 19060911 24886709 21347282 25961943 26780889 20686565 26582766) HDL Cholesterol - Triglycerides (HDLC-TG) ( 21386085) HDL cholesterol change in response to niacin in statin-treated individuals ( 30371334) HDL Cholesterol in HIV-infection ( 25884002) HDL cholesterol levels ( 32203549 31694877 28334899 26690388 26763881 17463246 30698716) HDL cholesterol levels in current drinkers ( 30698716) HDL cholesterol levels in HIV infection ( 33109212) HDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716) HDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716) HDL cholesterol levels x long total sleep time interaction (2df test) ( 31719535) HDL cholesterol levels x short total sleep time interaction (2df test) ( 31719535) Hematological and biochemical traits ( 20139978) High density lipoprotein cholesterol levels ( 30263045 30718733 33499410 31211820 32902719 31647587 30911093 29403010 33339817 31217584 28548082 30108155) Hypo-HDL-cholesterolemia ( 31087446) LDL cholesterol ( 24097068 25961943 20686565) LDL cholesterol levels ( 32203549 28334899 30698716) LDL cholesterol levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716) LDL cholesterol levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716) Lipid metabolism phenotypes ( 22286219 19936222) Lipid or lipoprotein levels ( 23696881) Lipid traits ( 30576415 24386095 24023260 24023261) Lipoprotein-associated phospholipase A2 activity and mass ( 22003152 23118302) Low density lipoprotein cholesterol levels ( 33339817) Low HDL-cholesterol levels ( 31910446) Low high density lipoprotein cholesterol levels ( 26879886) Metabolic syndrome ( 22399527 21386085 20694148 31589552) Metabolic syndrome (bivariate traits) ( 21386085) Metabolically unhealthy in normal weight ( 33500527) Metabolically unhealthy in obesity ( 33500527) Metabolite levels ( 22916037) Metabolite levels (lipoprotein measures) ( 27005778) Response to fenofibrate (HDL cholesterol levels) ( 30263045) Response to statins (HDL cholesterol change) ( 27587472) Serum metabolite levels ( 31636271 33031748) Serum metabolite levels (CMS) ( 31636271) Total cholesterol levels ( 30718733 28334899 29403010 33339817) Triglyceride levels ( 32203549 28334899 29403010 33339817) Triglyceride levels in current drinkers ( 30698716) Triglyceride levels x alcohol consumption (drinkers vs non-drinkers) interaction (2df) ( 30698716) Triglyceride levels x alcohol consumption (regular vs non-regular drinkers) interaction (2df) ( 30698716) Triglyceride levels x long total sleep time interaction (2df test) ( 31719535) Triglyceride levels x short total sleep time interaction (2df test) ( 31719535) Triglycerides ( 24097068 25961943 20686565) Waist circumference and related phenotypes ( 18454146)	Metabolite levels ( 23823483) Night sleep phenotypes ( 27126917)
Interacting Genes		7 interacting genes: APOA1 ARPC3 BBS2 EWSR1 LPL PRKACG TP53	5 interacting genes: CDK17 CETP HMGN1 TNP1 TNP2
Entrez ID		1071	5568
HPRD ID		00325	01483
Ensembl ID		ENSG00000087237	ENSG00000165059
Uniprot IDs		A0A0S2Z3F6 A0A0S2Z3I8 B4DMZ5 P11597	P22612
PDB IDs		2OBD 4EWS 4F2A
Enriched GO Terms of Interacting Partners?
Tagcloud ?
Tagcloud (Difference) ?
Tagcloud (Intersection) ?